Evinova
↗Cambridge, United Kingdom (Regional offices in North America, Europe, and Asia-Pacific)
Evinova is a digital health technology company launched by AstraZeneca in November 2023 to provide AI-enabled solutions for accelerating clinical trials and life sciences development. The company operates as a standalone business within the AstraZeneca group, combining deep pharmaceutical expertise with cutting-edge digital and AI capabilities. Evinova offers a comprehensive suite of digital health solutions including unified trial platforms, AI-powered study design and planning tools, portfolio management systems, and remote patient monitoring capabilities. The platform helps pharmaceutical sponsors, biotech companies, and Contract Research Organizations optimize the entire clinical development lifecycle from trial design to execution.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health / Health-Tech / Clinical Research Technology
Sub-Industry:Clinical Trial Technology, AI/ML for Drug Development
SIZE & FINANCIALS
Employees:201-500
Founded:2023
Ownership:subsidiary
Status:operating
FUNDING
Stage:Subsidiary of Public Company
Investors:AstraZeneca (Parent Company)
PIPELINE
Stage:Commercial
Lead Drug Stage:Not applicable (technology/services company)
Modalities:Digital health platforms, AI/ML algorithms, Remote patient monitoring, Electronic clinical outcome assessment
CORPORATE STRUCTURE
Parent Company:AstraZeneca
Key Partnerships:Parexel - Global CRO offering Evinova solutions to customers, Fortrea - Global CRO offering Evinova solutions to customers, Accenture - Technology and implementation partner, Amazon Web Services (AWS) - Cloud infrastructure and AI/ML capabilities, Quantum Leap Healthcare Collaborative (QLHC) - Breast cancer trial integration (2025), Harbour BioMed - Strategic AI collaboration for drug development (2025)
COMPETITION
Position:Emerging Leader
Competitors:Medidata (Dassault Systèmes), Oracle Health Sciences, TransCelerate BioPharma, Veeva Vault, Clinical Development Solutions (proprietary pharma systems)
LEADERSHIP
Key Executives:
Cristina Durán - President
Sean Connolly - Vice President & Chief Technology Officer
Andrea Rudy Rubio - Chief Financial Officer & Board Member
Jill Bell - VP/Senior Leadership Role
James Thatcher - Vice President, Business Development
Dawn Plowman - Director, Human Resources
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Evinova. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.